Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,257Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Farmabios S.p.A.

02 1AX Pharmaceutical Corp

03 1Catalent Micron Technologies, Inc.

04 1Cipla Ltd.

05 1Curia Spain S.A.U.

06 1Curia Wisconsin, Inc.

07 1Fagron Inc

08 1Pfizer Asia Manufacturing Pte Ltd

09 1STERLING SPA

10 1ScinoPharm Taiwan Ltd.

11 1Shandong Anhong Pharmaceutical Co., Ltd.

12 2Sterling Chemical Malta Ltd

13 1Sterling S.p.A.

14 1Symbiotica Speciality Ingredients Sdn. Bhd.

15 1Viatris Pharmaceuticals LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

EXEMESTANE

NDC Package Code : 46439-8746

Start Marketing Date : 2012-07-19

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Axplora CB

02

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

EXEMESTANE

NDC Package Code : 62157-091

Start Marketing Date : 2015-05-22

End Marketing Date : 2020-12-31

Dosage Form (Strength) : POWDER (49.5g/50g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

03

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

EXEMESTANE

NDC Package Code : 53104-7666

Start Marketing Date : 2016-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

04

BePharma
Not Confirmed
arrow

05

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

EXEMESTANE

NDC Package Code : 51552-1619

Start Marketing Date : 2021-10-07

End Marketing Date : 2026-03-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

06

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

EXEMESTANE

NDC Package Code : 49386-026

Start Marketing Date : 2019-12-24

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (10kg/10kg)

Marketing Category : BULK INGREDIENT

blank

07

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

EXEMESTANE

NDC Package Code : 59057-007

Start Marketing Date : 2018-02-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

08

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

EXEMESTANE

NDC Package Code : 59057-008

Start Marketing Date : 2018-02-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

BePharma
Not Confirmed
arrow

Looking for 107868-30-4 / Exemestane API manufacturers, exporters & distributors?

Exemestane manufacturers, exporters & distributors 1

85

PharmaCompass offers a list of Exemestane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Exemestane manufacturer or Exemestane supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Exemestane manufacturer or Exemestane supplier.

PharmaCompass also assists you with knowing the Exemestane API Price utilized in the formulation of products. Exemestane API Price is not always fixed or binding as the Exemestane Price is obtained through a variety of data sources. The Exemestane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Exemestane

Synonyms

107868-30-4, Aromasin, 6-methyleneandrosta-1,4-diene-3,17-dione, Fce 24304, Fce-24304, Exemestano

Cas Number

107868-30-4

Unique Ingredient Identifier (UNII)

NY22HMQ4BX

About Exemestane

Exemestane is an irreversible steroidal aromatase inhibitor, with antiestrogen and antineoplastic activities. Upon oral administration, exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the peripheral aromatization of androgens, including androstenedione and testosterone, to estrogens. This lowers estrogen levels in the blood circulation.

Exemestane Manufacturers

A Exemestane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Exemestane, including repackagers and relabelers. The FDA regulates Exemestane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Exemestane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Exemestane manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Exemestane Suppliers

A Exemestane supplier is an individual or a company that provides Exemestane active pharmaceutical ingredient (API) or Exemestane finished formulations upon request. The Exemestane suppliers may include Exemestane API manufacturers, exporters, distributors and traders.

click here to find a list of Exemestane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Exemestane NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Exemestane as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Exemestane API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Exemestane as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Exemestane and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Exemestane NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Exemestane suppliers with NDC on PharmaCompass.

Exemestane Manufacturers | Traders | Suppliers

Exemestane Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.